BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 13, 2012
View Archived Issues
Catabasis Pharmaceuticals synthesizes novel inhibitors of NF-kappaB signaling
Read More
Fred Hutchinson and GSK partner to develop muscular dystrophy therapeutics
Read More
Stemline Therapeutics describes MAb conjugate against IL-3R-alpha
Read More
PDC Biotech completes phase I trial of PDC-13 in primary dysmenorrhea
Read More
Sucampo receives milestone payment for first sale of Amitiza in Japan
Read More
Anacor discloses results from phase II trial of AN-2728
Read More
Pharmascience regains global rights to IAP inhibitor oncology program
Read More
Phase IIb study commences for inhaled LAMA candidate for the treatment of COPD
Read More
Interim data from phase I study of IPH-2101 plus lenalidomide reported
Read More
Durata Therapeutics reports phase III data for dalbavancin
Read More
uniQure begins phase I study in acute intermittent porphyria
Read More
KaloBios Pharmaceuticals KB-003 for chronic myelomonocytic leukemia
Read More
New phase IIb study of Zorcell psoriasis vaccine begins
Read More
Medicago receives support for influenza vaccine programs
Read More
Dosing begins in CUPID trial of Mydicar in advanced heart failure
Read More
Researchers design potent domain antibody inhibitors of amyloid formation
Read More
TiGenix presents novel immunomodulatory cells for MS
Read More
New fusion proteins disclosed by the National Institute of Immunology
Read More
Researchers at Bristol-Myers Squibb synthesize new HCV NS5A inhibitors
Read More
FORMA Therapeutics patents new NAmPRTase inhibitors
Read More
Eli Lilly shifts focus of phase III solanezumab trials
Read More
Vernalis' study of V-81444 confirms dose for proof-of-concept trial
Read More
Boehringer Ingelheim discontinues phase II dabigatran etexilate trial
Read More
Novel GR antagonists discovered to prevent antipsychotic-induced weight gain
Read More
NADPH oxidase 4 identified as therapeutic target in asthma
Read More
New product for congenital factor XIII deficiency launched
Read More